Literature DB >> 33039011

Tackling the Patient with Multiple Drug "Allergies": Multiple Drug Intolerance Syndrome.

Autumn Guyer1, Melissa Iammatteo2, Merhunisa Karagic3, Eric Macy4, Elina Jerschow5.   

Abstract

As populations age, the prevalence of reported drug "allergy" increases, often leading to suboptimal care and increased morbidity because of unnecessary avoidance of safe and effective medications. Evaluation by a drug allergy specialist is often warranted when a patient has more than 2 unrelated drug "allergies" listed in the medical record. In this commentary, we clarify and propose standard terminology to use when evaluating patients with multiple drug allergy labels including and more specifically when diagnosing multiple drug intolerance syndrome and the much rarer multiple drug hypersensitivity syndrome. We review epidemiology and key features of multiple drug intolerance syndrome and multiple drug hypersensitivity syndrome. We summarize the methodologic and practical diagnostic workup and management of individuals with MDIS to assist with the accurate delabeling of drug "allergies" in the electronic health record.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Drug allergy; Drug challenge; Drug hypersensitivity; Drug intolerance; Multiple drug hypersensitivity syndrome; Multiple drug intolerance syndrome

Mesh:

Substances:

Year:  2020        PMID: 33039011     DOI: 10.1016/j.jaip.2020.08.033

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  2 in total

1.  Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting.

Authors:  Grace Koo; Joanna L Stollings; Christopher Lindsell; Mary Lynn Dear; Sunil Kripalani; George E Nelson; Allison B McCoy; Todd W Rice; Elizabeth J Phillips; Cosby A Stone
Journal:  J Allergy Clin Immunol Pract       Date:  2022-02-05

2.  Characterization, epidemiology and risk factors of multiple drug allergy syndrome and multiple drug intolerance syndrome: A systematic review.

Authors:  Parbir K Jagpal; Saad Alshareef; John F Marriott; Mamidipudi Thirumala Krishna
Journal:  Clin Transl Allergy       Date:  2022-08-22       Impact factor: 5.657

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.